Glenmark Pharmaceuticals
GLENMARK.NS
#2529
Rank
$5.69 B
Marketcap
$20.16
Share price
1.47%
Change (1 day)
124.51%
Change (1 year)

Glenmark Pharmaceuticals (GLENMARK.NS) - Cash on Hand

Cash on Hand as of March 2024 : $0.21 Billion USD

According to Glenmark Pharmaceuticals 's latest financial reports the company has $0.21 Billion USD in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Glenmark Pharmaceuticals - Cash on Hand chart (from 2012 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-03-31$0.17 B-6.36%
2022-03-31$0.19 B15.11%
2021-03-31$0.16 B5.67%
2020-03-31$0.15 B-4.1%
2019-03-31$0.16 B-24.78%
2018-03-31$0.21 B15.74%
2017-03-31$0.18 B45.13%
2016-03-31$0.12 B4.23%
2015-03-31$0.12 B-8.42%
2014-03-31$0.13 B19.5%
2013-03-31$0.11 B73.92%
2012-03-31$65.09 M49.02%
2011-03-31$43.68 M82.86%
2010-03-31$23.88 M69.71%
2009-03-31$14.07 M-64.13%
2008-03-31$39.23 M60.18%
2007-03-31$24.49 M3.29%
2006-03-31$23.71 M-18.74%
2005-03-31$29.18 M1456.46%
2004-03-31$1.87 M